Archive for the ‘China Yongxin Pharmaceuticals Inc. CYXN’ Category

China Yongxin Pharmaceuticals Inc. (CYXN.OB) Introduces Diagnosis System to Thwart Prescription Drug Abuse in China

Monday, March 16th, 2009

China Yongxin Pharmaceuticals Inc. (CYXN.OB) today announced it has initiated use of its Electronic Diagnosis System throughout chain drugstores in Changchun, Jilin, as part of an effort to curb the abuse of prescription in the Jilin province.

The system provides a network for doctors to provide diagnosis services through an integrated video and audio system, allowing customers to immediately purchase treatment prescribed by the doctors in Yongxin’s chain drugstores. The company said the system reduces errors, improves efficiency, and will help thwart fake prescriptions.

According to China Yongxin, the system is the first of its kind to be introduced in the Jilin province. According to the company, if all goes well and the product is well received, it will initiate long-term plans to supply the system to all future and existing stores.

In the press release, Yongxin Liu, chairman and CEO of China Yongxin, said the company anticipates the Electronic Diagnosis System to become a key part of the company’s future and its position in the marketplace.

“We are very pleased to announce the launch this system, which has proven through trials to be a safe, reliable, convenient and efficient way to provide both medical diagnosis and prescription services to our retail patient customers. The system further improves the level of service and convenience we provide, and we expect it to be a significant driver to the future growth of our retail business,” Liu stated.

The technology received positive review from Yan Jiangyin, spokesperson and vice chief of Politics & Law Department of China’s State Food and Drug Administration, as well as coverage from Chinese Central TV, Chinese Medicine Newspaper, and other media outlets in the province.

China Yongxin expects the device to boost its revenues associated with prescription drugs, and will allow the company to extend its reach to more chain drug stores in northern China.

“During first 9 months of 2008, revenues generated from prescription drugs represented approximately 25% of total drugstore sales and contribute gross margins of approximately 23.5%. We expect revenues from prescription drugs in these stores equipped with this system to increase by approximately 20% during the next year as the market adopts this new service offering. Our focus on further improving the quality of our service combined with expanding the number of chain drugstores we operate will enable us to gain incremental market share in Northern China and position the company for continued future growth,” Liu stated.

Let us hear your thoughts below:

China Yongxin Pharmaceuticals, Inc. (CYXN): Profitable Company with 93 Drugstores for 6 Cents a Share?

Monday, December 8th, 2008

China Yongxin Pharmaceuticals, Inc. is probably the most undervalued company we’ve ever written about. It isn’t everyday that you find a growing, profitable company with nearly 100 stores trading for such a discounted stock price.

The company is more than just a drug retailer as they also produce and distribute pharmaceutical products. The company’s products include Chinese traditional medicines, chemical pharmaceutical preparations, natural health products, healthy food, cosmetics, and medical equipment.

Just last month the company released its financial results for Q3 2008 which revealed that net income doubled year-over-year to $1.7 million, or $0.05 per diluted share. However, even with consistent growth and excellent expenditure management, the stock is trading at a P/E ratio of less than one! If the stock was trading at its peers’ P/E ratio, it would be over $2 a share.

According to a CEO letter released earlier this year, the company is preparing to take its winning formula to a wider area across China to accelerate its growth rate. The CEO also stated that every decision made by the company’s management will be made to enhance shareholder investment. So far the company has shown exceptional proficiency relative to their current stock price and we look forward to seeing where they will be in the future.

Let us hear your thoughts below:

China Yongxin Pharmaceuticals Inc. (CYXN.OB) is “One to Watch”

Tuesday, December 2nd, 2008

China Yongxin Pharmaceuticals Inc. began in 1993 as Changchun Yongxin Dirui Medical Co., Ltd. (Yongxin), a wholesale drug distributor. The Company’s products include Chinese traditional medicines, chemical preparations, natural health products, cosmetics, and medical equipment. On May 20, 2008, China Yongxin Pharmaceuticals Inc. announced that they completed their reverse merger with Nutradyne Group, Inc. To reflect their true business, they changed their corporate name to China Yongxin Pharmaceuticals Inc. and their ticker symbol to “OTCBB: CYXN.” Today, they are a leading manufacturer, distributor, and retailer of pharmaceuticals in Northeastern China.

China Yongxin began retail operations in 2001. In 2005, the Company acquired China’s Jilin Province franchise rights from Medicine Shoppe China Inc. The Company became a rapidly growing medicine distributor and retailer by the end of 2007. Currently, they have five subsidiaries including 93 chain pharmacies.

In November, China Yongxin Pharmaceuticals, Inc. announced financial results for the third quarter ended September 30, 2008. Revenue increased 9.8 percent year-over-year to $15.5 million. Gross margin increased 3.6 percent to 19.7 percent compared to the previous year. The Company’s net income more than doubled to $1.7 million or $0.05 per diluted share over the prior year.

Today, China Yongxin Pharmaceuticals announced that they recently established a Retailing Chain Management Head Office to uniformly manage their growing base of chain drugstores.

“We established the Retailing Chain Management Head Office to further the implementation of our 5-year strategic development plan for the retailing chain business of China Yongxin,” stated Mr. Yongxin Liu, Chairman, and CEO of China Yongxin Pharmaceuticals, Inc.

Let us hear your thoughts below:

China Yongxin Pharmaceuticals, Inc. (CYXN.OB) Signs Exclusive Franchise Agreement with Multi-Billion Dollar Drug Chain

Monday, June 30th, 2008

China Yongxin Pharmaceuticals, a leading manufacturer, distributor and retailer of pharmaceuticals in Northeastern China, has signed a 10-year franchise agreement with one of the world’s largest US-based drug chains. The name of the chain was not released for competitive reasons, but the agreement will allow China Yongxin to use the drug chain’s brand name in operating drug chain stores in Jilin Province.

According to the terms of the agreement, the company will have exclusive rights to the brand name in operations in Jilin Province, which includes the City of Changchun. China Yongxin will convert 87 of its existing stores in Jilin Province to branded stores during the first three years of the contract, as well as operate at least half of its new stores under this brand. By the end of the year, China Yongxin expects to have at least eight branded stores in operation, either through conversions or new store openings.

The contract gives China Yongxin a couple of added benefits as well. First, the multi-billion dollar drug chain gives them the marketing power of a globally recognized brand of one of the world’s leading pharmacy franchisors. Finally, it will help with the planned expansion of China Yongxin into additional Chinese provinces because the agreement helps to confirm its status as one of the fastest-growing retail drug store chains in China.

Yongxin Liu, China Yongxin Pharmaceutical’s chairman and CEO, commented, “The decision by our new partner to choose our company to represent its brand of retail drug stores, beginning with Jilin Province, testifies to the industry’s recognition and acceptance of our company’s proven model of vertical integration and aggressive, yet systematic growth. We believe that the ongoing expansion of our retail drug chain stores, wholesale distribution and manufacturing subsidiaries should position us as one of the fastest-growing players in one of the world’s largest drug and pharmaceutical markets in the world.”

Let us hear your thoughts below:

Small Cap Voice Featured Company: China Yongxin Pharmaceuticals, Inc. (CYXN.OB)

Tuesday, May 27th, 2008

China Yongxin Pharmaceuticals, Inc. (CYXN.OB) is a large medical supplier located in China. The company provides approximately 80% of Northeast China’s medical supplies. China Yongxin owns and operates four subsidiaries that include a wholesale division and a retail division.

China Yongxin’s wholesale division is responsible for the distribution of pharmaceuticals and medical supplies. The company owns and operates a retail pharmacy chain and a retail drugstore chain with 96 operating drug and pharmaceutical stores. They also have retail operation as a franchisee of American Medicine Shoppe International, and they manufacture proprietary ginseng products.

China Yongxin plans to add 102 new retail drug and pharmaceutical stores in 2008. In 2007, the company reported net revenues of $47,892,833.00, which was an increase of 20% from the year ending 2006.

Let us hear your thoughts: China Yongxin Pharmaceuticals, Inc. Message Board